skip to Main Content

A Prospective Study to Establish a New Onset Diabetes (NOD) Cohort

In this study we are estimating the risk of pancreatic ductal adenocarcinoma among individuals NOD (New Onset Diabetes) Protocol defined hyperglycemia by study status (enrolled, not enrolled, not recruited). We will also participate in a national multi-site effort to build a biorepository that will be used to develop and/or test biomarkers for early detection of pancreatic cancer.

Investigator: Van Den Eeden, Stephen

Funder: National Institute of Diabetes and Digestive and Kidney Diseases

Explore all studies and publications

Back To Top